![MyNeuroNews](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/144/normal/Screenshot_2019-07-30_at_09.20.34.png?1564474985)
Repetitive Erythropoietin Treatment Improves Long-Term Neurocognitive Outcome by Attenuating Hyperoxia-Induced Hypomyelination in the Developing Brain
MyNeuroNews,
Introduction: Preterm infants born before 28 weeks of gestation are at high risk of neurodevelopmental impairment in later life.